pankajvalvi

Right to Information Act, 2005

by

An Act to provide for setting out the practical regime of Right to Information for citizens to secure access to information under the control of public authorities, in order to promote transparency and accountability in the working of every public authority, the constitution of a Central Information Commission and State Information Commissions and for matters … Read more

What is New Drug Application (NDA), Investigational New Drug (IND), and Abbreviated New Drug Application (ANDA)?

by

New Drug Application (NDA), Investigational New Drug (IND), Abbreviated New Drug Application (ANDA)

New_Drug_Application

The New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing.

The investigational new drug (IND) application is the result of a successful preclinical development program. The IND is also the vehicle through which a sponsor advances to the next stage of drug development known as clinical trials (human trials).

An Abbreviated New Drug Application (ANDA) contains data submitted to FDA’s Center for Drug Evaluation and Research, Office of Generic Drugs, for review and ultimate approval of a generic drug product.

Read more

New Drug Application (NDA), Investigational New drug (IND), Abbreviated New Drug Application (ANDA)

by

The New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. The investigational new drug (IND) application is the result of a successful preclinical development program. The IND is also the vehicle through which a sponsor advances … Read more

Abbreviated New Drug Application

by

An application for a license to market a generic (or a duplicate) version of a drug that has already been granted an approval under a full NDA. Generic drug applications are termed “abbreviated” because they are not required to provide clinical data to establish safety and efficacy, since these parameters have already been established. ANDA